First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

Left atrial appendage occlusion in patients with atrial fibrillation: focus on current evidence and commercially available

TCT DAIC

The Watchman FLX Device: First European Experience and Feasibility of Intracardiac Echocardiography to Guide Implantation - ScienceDirect

Watchman Archives - Cardiovascular News

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

Percutaneous Left Atrial Appendage Occlusion Therapy: Evolution and Growing Evidence

Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

First Comparison of Amulet and Watchman FLX LAA Closure Devices Found Similar Outcomes

Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device

Diagnostic and Interventional Cardiology

LAA Closure

Left Atrial Appendage Closure for Stroke Risk Reduction in Nonvalvular Atrial Fibrillation - The Cardiology Advisor

Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta‐analysis - Zhu - 2022 - Pacing and Clinical Electrophysiology - Wiley Online Library

The Spectrum of Devices for Percutaneous Left Atrial Appendage Occlusion - Cardiac Interventions Today

Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology